Objective
FLEXPOL aims to develop a pilot line for the production of a cost effective antimicrobial (AM) adhesive film for its use in hospitals.
The obtained adhesive film will inhibit growth of a wide range of microbes and will be suitable for high-touch surfaces, providing a durable protection with good resistance. It will assure the highest level of hygiene and patient safety, reducing the use of disinfectants.
These objectives will be achieved, using a multi-functional approach combining prevention of adhesion with killing of microorganisms, by means of essential oil (EO) emulsions embedded in a micro and nanopatterned polypropylene matrix.
FLEXPOL covers the following key aspects:
-It addresses the development, upscaling and demonstration in a relevant industrial environment of the production of films with AM, biocompatible and anti-adhesive properties. Existing extrusion and nanoimprinting pilot lines will act as the starting point in which new additives based on blends of EO will be incorporated.
-Previously validated technologies constitute the basis of the approach. These technologies will be extended to large scale production and demonstrated in a real operational environment. The pilot line will include real time characterization for inspection of the film at the nanoscale.
-Robustness and repeatability of film fabrication and its behavior in a real environment will be studied. The effectiveness of the solution will be compared with standard protocols.
-Materials are chosen according to their cost for large-scale application. Productivity and cost of the fabrication process will be analyzed attending to energetic optimization of the product fabrication and the raw material cost.
-Access to the pilot line for AM films in this or a different application will be ensured to European Industries at a cost that promotes technology transfer.
-Non-technological aspects key for the marketing of the product (such as regulatory issues, HSE aspects, LCA...) are considered.
Fields of science
- natural sciencesbiological sciencesmicrobiologybacteriology
- natural sciencesphysical sciencesastronomyplanetary sciencesplanetary geology
- natural sciencesbiological sciencesmicrobiologymycology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Programme(s)
Funding Scheme
IA - Innovation actionCoordinator
80686 Munchen
Germany
See on map
Participants (11)
20600 Eibar Guipuzcoa
See on map
CB1 7EG Cambridge
See on map
4704 553 Braga
See on map
20014 Donostia-san Sebastian
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
01006 Vitoria-gasteiz
See on map
08193 Cerdanyola Del Valles
See on map
10098 Rivoli To
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
03690 Alicante
See on map
Participation ended
47122 Forli
08225 Terrassa Barcelona
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
46980 Paterna Valencia
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.